Community pharmacy-based nasopharyngeal sampling is safe and feasible for respiratory virus surveillance in New Zealand
A multi-centre study in New Zealand demonstrates that community pharmacy-based nasopharyngeal sampling is a safe, feasible, and acceptable method for respiratory virus surveillance, offering comparable detection rates to existing systems while improving access for underserved populations and capturing a higher proportion of rhinovirus cases.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Tracking the invisible waves of viruses that sweep through our communities is a critical task for public health. To understand how respiratory illnesses like the flu or common cold spread, scientists need to know which specific viruses are circulating, how common they are, and who is getting sick. Traditionally, this information comes from people who are sick enough to visit a doctor or a hospital. However, this method has a blind spot: it often misses those who are too busy, too far away, or too concerned about the cost of a medical appointment to seek professional help. If the data only captures the most severe cases or those with easy access to care, health officials might get an incomplete picture of the true situation, making it harder to prepare for future outbreaks or pandemics.
In New Zealand, researchers set out to see if they could fill this gap by turning to a different kind of health hub: the local community pharmacy. These stores are already trusted places where people go for advice on minor illnesses, often without needing a formal appointment. The team wanted to know if pharmacists could safely and effectively collect the same high-quality samples used in hospitals to test for viruses, and if doing so would reach a different group of people than the current system does. They focused on a specific type of sample called a nasopharyngeal swab, which involves gently collecting cells from the very back of the nose. While this method is the gold standard for accuracy, it is usually reserved for doctors and nurses because it requires training and can be slightly uncomfortable.
The study took place over two winter seasons and one period between seasons, involving twenty-two community pharmacies across the country. Trained investigators in these pharmacies approached adults who had a fever and a cough, symptoms typical of a respiratory infection. After getting permission, these investigators collected the nasal swabs and sent them to a national laboratory for detailed analysis. The goal was to compare the results from these pharmacy visits with the data coming from the existing network of general practitioners, or family doctors. The researchers were looking for two main things: whether the pharmacy staff could perform the procedure safely without causing harm, and whether the viruses they found matched the patterns seen in the doctor's offices.
The results showed that the pharmacy-based approach worked remarkably well. The staff collected samples from hundreds of people, and the process was safe, with only two minor instances of nosebleeds reported out of nearly five hundred attempts. When the scientists analyzed the samples, they found that the overall rate of virus detection in the pharmacies was almost identical to the rate found in general practices. This suggests that the pharmacies were successfully identifying people who were actually sick with a respiratory virus, just as the doctors were. The data flowed smoothly from the local stores to the national lab, proving that the logistics of this new system were sound.
However, the type of viruses found in the pharmacies told a slightly different story about the people being reached. While the overall numbers were similar, the pharmacies detected significantly more rhinovirus, which is a common cause of the mild cold, and fewer cases of influenza, which often causes more severe illness. This difference makes sense when considering who visits a pharmacy versus a doctor. People with a mild cold might feel well enough to pop into a pharmacy for advice but might not bother making a doctor's appointment. Conversely, people with the flu often feel too unwell to leave home or feel they need the stronger care a doctor provides. By capturing these milder cases, the pharmacy system offered a broader view of the virus landscape, including infections that the traditional doctor-based system might miss.
The people who participated in the study were overwhelmingly positive about the experience. The vast majority said they found it convenient to get tested while asking for advice on their symptoms, and nearly all of them said they would be willing to do it again. They also expressed high confidence in the pharmacists' ability to perform the swab correctly. The pharmacists and pharmacy owners who took part in the study felt similarly, with most saying they would participate again and that the procedure was easy to understand and execute. This high level of trust and comfort is crucial, as it suggests that this model could be sustained over the long term.
The study also highlighted that this approach could help reach people who are often left out of health data. The group of people tested in the pharmacies included a higher proportion of working-age adults and a slightly different mix of ethnic backgrounds compared to the group seen by doctors. While the study did not reach every demographic equally, it demonstrated that community pharmacies can act as a bridge to populations that might otherwise avoid the healthcare system due to cost or inconvenience. The researchers noted that the system worked best when people were already registered with a doctor, which is a current limitation, but the core finding remains clear: using local pharmacies to collect virus samples is a safe, feasible, and effective way to expand how a country monitors respiratory health.
By proving that community pharmacies can handle the task of collecting high-quality virus samples, this work opens the door for a more inclusive and responsive surveillance network. It suggests that in the future, health officials might be able to get a clearer, more complete picture of how viruses are moving through the population by tapping into the everyday interactions people have with their local pharmacists. This does not replace the need for doctors or hospitals, but it adds a vital layer to the system, ensuring that the data used to guide public health decisions reflects the reality of the entire community, not just those who can easily access a clinic.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.